You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Retinal disease due to RPE65 mutations

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Amaurosis of Leber, Retinal Diseases Trial in Gainesville, Philadelphia (rAAV2-CBSB-hRPE65)

Active, not recruiting
  • Amaurosis of Leber
  • Retinal Diseases
  • rAAV2-CBSB-hRPE65
  • Gainesville, Florida
  • +1 more
Dec 13, 2021

Inherited Retinal Dystrophy Due to RPE65 Mutations, Leber Congenital Amaurosis Trial in Iowa City, Philadelphia

Active, not recruiting
Has Results
  • Inherited Retinal Dystrophy Due to RPE65 Mutations
  • Leber Congenital Amaurosis
  • AAV2-hRPE65v2,voretigene neparvovec-rzyl
  • Iowa City, Iowa
  • +1 more
Dec 9, 2021

Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2)

Active, not recruiting
  • Inherited Retinal Dystrophy Due to RPE65 Mutations
  • AAV2-hRPE65v2
  • (no location specified)
Dec 9, 2021

Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Dallas, Madison, London (QR-421a, Sham-procedure)

Active, not recruiting
  • Retinitis Pigmentosa
  • +7 more
  • Dallas, Texas
  • +2 more
Apr 21, 2022

Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)

Recruiting
  • Retinitis Pigmentosa
  • +7 more
  • San Diego, California
  • +14 more
Jul 29, 2022

Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Canada, France, United States (QR-421a, Sham-procedure (dose

Completed
  • Retinitis Pigmentosa
  • +7 more
  • QR-421a
  • Sham-procedure (dose cohort 1&2 only)
  • Boston, Massachusetts
  • +6 more
Apr 19, 2022

Retinal Disease, Retinitis Pigmentosa Trial in Riyadh (Subretinal administration of rAAV2-VMD2-hMERTKRecombinant

Completed
Has Results
  • Retinal Disease
  • Retinitis Pigmentosa
  • Subretinal administration of rAAV2-VMD2-hMERTKRecombinant Adeno-Associated Virus
  • Riyadh, Saudi Arabia
    King Khaled Eye Specialist Hospital
Jan 25, 2022

Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis Trial in Worldwide (sepofarsen)

Recruiting
  • Leber Congenital Amaurosis 10
  • +10 more
  • Ghent, Belgium
  • +8 more
Mar 24, 2022

Retinal Disorder Trial in New York (Placebos, ZA Low dose, ZA high dose)

Suspended
  • Retinal Disorder
  • Placebos
  • +2 more
  • New York, New York
    NY NY
Oct 7, 2020

Leber Congenital Amaurosis Associated With Mutations in RPE65

Recruiting
  • Leber Congenital Amaurosis
    • Ann Arbor, Michigan
    • +1 more
    Apr 7, 2022

    Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

    Recruiting
    • Rare Disorders
    • +309 more
      • Sioux Falls, South Dakota
      • +1 more
      Jun 20, 2022

      Cell Collection to Study Eye Diseases

      Recruiting
      • Retinal Disease
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 23, 2023

        Leber Congenital Amaurosis Trial in Shanghai (HG004)

        Recruiting
        • Leber Congenital Amaurosis
        • HG004
        • Shanghai, Shanghai, China
          Xinhua Hospital affiliated with Shanghai Jiao Tong University Sc
        Sep 26, 2023

        Biallelic RPE65 Mutation-associated Retinal Dystrophy Trial in Beijing (FT-001 Low Dose, FT-001 Mid Dose, FT-001 High Dose)

        Recruiting
        • Biallelic RPE65 Mutation-associated Retinal Dystrophy
        • FT-001 Low Dose
        • +2 more
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        May 11, 2023

        Natural History of Eye Diseases Related to ABCA4 Mutations

        Active, not recruiting
        • Retinal Degeneration
        • ABCA4-Related Retinopathies
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Feb 2, 2023

          Leber Congenital Amaurosis Trial (HG004)

          Not yet recruiting
          • Leber Congenital Amaurosis
          • (no location specified)
          Jun 13, 2023

          Mutations Under Inherited Retinal Disease in Korean

          Completed
          • Inherited Retinal Dystrophy Primarily Involving Sensory Retina
          • Inherited Retinal Dystrophy Primarily Involving Retinal Pigment Epithelium
            • Seoul, Korea, Republic of
              Gangnam Severance Hospital
            Oct 18, 2021

            Adaptive Optics Imaging of Outer Retinal Diseases

            Recruiting
            • Retinal Degeneration
            • +9 more
            • Adaptive optics imaging
            • Bethesda, Maryland
            • +1 more
            Apr 25, 2022

            PCDH15-Related Retinal Degeneration in Usher Syndrome 1F

            Recruiting
            • Retinal Degeneration
            • +2 more
              • San Francisco, California
              • +7 more
              Jan 12, 2022

              LCA5 Trial (AAV8.hLCA5)

              Not yet recruiting
              • LCA5
              • AAV8.hLCA5
              • (no location specified)
              Nov 22, 2022

              Leber Congenital Amaurosis Trial in Jerusalem (rAAV2-hRPE65)

              Completed
              • Leber Congenital Amaurosis
              • rAAV2-hRPE65
              • Jerusalem, Israel
                Hadassah Medical Organization
              Apr 8, 2018

              Retinitis Pigmentosa Trial in Ankara (Wharton's jelly derived mesenchymal stemcells, Magnovision)

              Completed
              • Retinitis Pigmentosa
              • Wharton's jelly derived mesenchymal stemcells
              • Magnovision
              • Ankara, Gölbaşı, Turkey
              • +2 more
              Mar 23, 2023

              To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)

              Not yet recruiting
              • To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)
              • (no location specified)
              Aug 29, 2023

              Glaucoma, Primary Open Angle Trial in Silver Spring (oxygen inhalation, Adaptive optics imaging)

              Recruiting
              • Glaucoma, Primary Open Angle
              • oxygen inhalation
              • Adaptive optics imaging
              • Silver Spring, Maryland
                Food and Drug Administration
              May 6, 2022

              Branch Retinal Vein Occlusion Trial in Worldwide (Brolucizumab 6 mg, Aflibercept 2 mg, Sham injection)

              Terminated
              Has Results
              • Branch Retinal Vein Occlusion
              • Brolucizumab 6 mg
              • +2 more
              • Phoenix, Arizona
              • +101 more
              Jan 27, 2023